Gilthanis
[H]ard|DCer of the Year - 2014
- Joined
- Jan 29, 2006
- Messages
- 8,753
Right now we are developing methods for polyharmacological drugs development. Dual-targeting drugs.
As case study is taken goal to develop Tankyrase and PI3K inhibitors for treatment of colorectal cancer. This is relevant to other cancers as well. Especially are targeted those cancers, which have cancer stem cells actively involved and cancers on metastasis stage.
This project just got re-vitalized. The page is still under development so some links aren't working. However, they are working on both CPU and GPU work units. It's always nice to find another bio/medical GPU project. Crossing my fingers.
https://boinc.drugdiscoveryathome.com/